31 – 40 of 40
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- « previous
- 1
- 2
- 3
- 4
- next »
- 2006
-
Mark
Expression of matrix metalloproteinase-2 and mutant p53 is increased in hydatidiform mole as compared with normal placenta
- Contribution to journal › Article
-
Mark
Combretastatin A-1 phosphate potentiates the antitumor activity of carboplatin and paclitaxel in a severe combined immunodeficiency disease (SCID) mouse model of human ovarian carcinoma.
- Contribution to journal › Article
-
Mark
Insulin-like growth factor-1 genotype predicts breast volume after pregnancy and hormonal contraception and is associated with circulating insulin-like growth factor-1 levels: implications for risk of early-onset breast cancer in young women from hereditary breast cancer families.
- Contribution to journal › Article
- 2004
-
Mark
A prospective population-based management program including primary surgery and postoperative risk assessment by means of DNA ploidy and histopathology. Adjuvant radiotherapy is not necessary for the majority of patients with FIGO stage I-II endometrial cancer
- Contribution to journal › Article
- 2003
-
Mark
First-line treatment of ovarian cancer FIGO stages IIb-IV with paclitaxel/epirubicin/carboplatin versus paclitaxel/carboplatin
- Contribution to journal › Article
- 2002
-
Mark
TP53 protein expression analysis by luminometric immunoassay in comparison with gene mutation status and prognostic factors in early stage endometrial cancer
- Contribution to journal › Article
- 2000
-
Mark
BRCA1 and BRCA2 mutations in ovarian cancer : Covariation with specific cytogenetic features
- Contribution to journal › Article
- 1995
-
Mark
Identification of small areas of solid growth has a strong prognostic impact in differentiated endometrial carcinomas. A histopathologic and morphometric study
- Contribution to journal › Article
- 1992
-
Mark
Characterization of an estradiol-independent but estradiol-responsive growth phenotype in a human endometrial adenocarcinoma heterotransplanted into nude mice
- Contribution to journal › Article
-
Mark
Nuclear morphometry : a strong prognostic factor for survival after secondary surgery in advanced ovarian cancer
- Contribution to journal › Article
- « previous
- 1
- 2
- 3
- 4
- next »
